Fentanyl spray effective for breakthrough cancer pain, study says

05/1/2013 | Oncology Nurse Advisor online

Nurse researchers at Loma Linda University Medical Center in California found that fentanyl sublingual spray effectively treats breakthrough pain in cancer patients. The study presented at the Oncology Nursing Society's annual meeting found 88.5% of patients were satisfied with the treatment.

View Full Article in:

Oncology Nurse Advisor online

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Manager/Senior Manager, Health Services Analytics
Avalere Health
Washington, DC
Manager/Senior Manager, Health Economist
Avalere Health
Washington, DC
Director, Health Services Analytics
Avalere Health
Washington, DC
Director/Vice President. Health Actuary
Avalere Health
Washington, DC
Attorney
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD